Table 1 Summary of data collection activities
Timing and site | 2018: February–April (T1) Kilifi | 2018: May (T2) Kilifi | 2019: May–July (Kilifi), September (Ahero) (T3) |
|---|---|---|---|
Study participants | • Study volunteers: Kilifi (n = 17) and Ahero (n = 15) • Study investigators/ clinicians (n = 3) • Kilifi study fieldworkers (n = 14) • Kilifi KCRs (n = 20) | • Former study volunteers from Kilifi (n = 5) | • Former study volunteers in Kilifi (n = 8) and Ahero (n = 10) • Study investigators/ clinicians (n = 5) • CLG Kilifi (n = 3) and Ahero CE staff (n = 1), • Kilifi study fieldworkers (n = 8) and Ahero CHVs (n = 4) • Community leaders in Kilifi (n = 3) and Ahero (n = 2) |
Purposive sampling criteria | All staff and study volunteers at in-patient stay with the exception of those who were experiencing malaria symptoms | Diversity in social and research experiences during residency | Diversity in gender, location, time of diagnosis and duration of in-patient stay |
Data collection methods (data collection team) | IDIs (n = 3) with study staff; FGDs with fieldworkers (n = 3), volunteers (n = 3) and KCRs (n = 3) (IJ/DK) | Follow-up IDIs (n = 5) (2 involved in residency FGDs) (IJ) | IDIs (n = 28) and pairs interviews (n = 8; with 16 persons) (EO/PCC) |
No. of study participants | 66 | 5 (2 participated in FGDs at T1) | 44 (16 participated in FGDs at T1) |